<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neurooncol Pract</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurooncol Pract</journal-id>
<journal-id journal-id-type="publisher-id">nop</journal-id>
<journal-title-group>
<journal-title>Neuro-Oncology Practice</journal-title>
</journal-title-group>
<issn pub-type="ppub">2054-2577</issn>
<issn pub-type="epub">2054-2585</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31579518</article-id>
<article-id pub-id-type="pmc">6760343</article-id>
<article-id pub-id-type="doi">10.1093/nop/npv051</article-id>
<article-id pub-id-type="publisher-id">npv051</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic counseling and tumor predisposition in neuro-oncology
practice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dunbar</surname>
<given-names>Erin M.</given-names>
</name>
<xref ref-type="aff" rid="d354e49"></xref>
<!--<email>john.henson@piedmont.org</email>-->
<xref ref-type="corresp" rid="d361e82"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eppolito</surname>
<given-names>Amanda</given-names>
</name>
<xref ref-type="aff" rid="d354e49"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Henson</surname>
<given-names>John W.</given-names>
</name>
<xref ref-type="aff" rid="d354e49"></xref>
</contrib>
</contrib-group>
<aff id="d354e49">
<addr-line>Piedmont Brain Tumor Center</addr-line>, <institution>Piedmont
Oncology</institution>, <addr-line>Atlanta, Georgia</addr-line> (E.M.D.);
<addr-line>Genetic Counseling Service</addr-line>, <institution>Piedmont
Oncology</institution>, <addr-line>Atlanta, Georgia</addr-line> (A.E.);
<addr-line>Piedmont Brain Tumor Center</addr-line>, <institution>Piedmont
Oncology</institution>, <addr-line>Atlanta, Georgia</addr-line> (J.W.H.)</aff>
<author-notes>
<corresp id="d361e82"><bold>Corresponding Author</bold>: John W. Henson, MD, Piedmont Oncology, 1800 Howell Mill
Road, Suite 625, Atlanta, GA 30318 (<email>john.henson@piedmont.org</email>).</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date iso-8601-date="2015-10-31" pub-type="epub">
<day>31</day>
<month>10</month>
<year>2015</year>
</pub-date>
<volume>3</volume>
<issue>1</issue>
<fpage>17</fpage>
<lpage>28</lpage>
<history>
<date date-type="received">
<day>31</day>
<month>7</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Â© The Author(s) 2015. Published by Oxford University Press on behalf of
the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail:
journals.permissions@oup.com.</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<self-uri xlink:href="npv051.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Tumor predisposition syndromes may be under-recognized in neuro-oncology practice.
Identifying patients with a hereditary tumor predisposition permits appropriate tumor
management as well as surveillance and risk-reduction measures for patients and their
families. The American College of Medical Genetics and Genomics and the National Society
of Genetic Counselors recently published referral guidelines for tumor predisposition
assessment, providing an impetus to review the use of genetic counseling in neuro-oncology
and to describe features of the less stereotypic conditions from the perspective of
neuro-oncology practice. This review also provides a framework for the identification and
management of these conditions, as well as references to guidelines and resources for
providers and patients.</p>
</abstract>
<kwd-group>
<kwd>brain tumor</kwd>
<kwd>familial</kwd>
<kwd>genetic</kwd>
<kwd>genetic counseling</kwd>
<kwd>hereditary</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>